Ameritas Investment Partners’s Verrica Pharmaceuticals VRCA Stock Holding History

Ameritas Investment Partners’s Portfolio VRCA Stock Details VRCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-172	Closed	-$762	–	3354
2025 Q1	$762	Hold	172	–	–	﹤0.01%	3112
2024 Q4	$1.21K	Hold	172	–	–	﹤0.01%	3115
2024 Q3	$2.5K	Hold	172	–	–	﹤0.01%	3091
2024 Q2	$12.6K	Hold	172	–	–	﹤0.01%	2839
2024 Q1	$10.2K	Hold	172	–	–	﹤0.01%	2809
2023 Q4	$12.6K	Hold	172	–	–	﹤0.01%	2770
2023 Q3	$6.7K	Hold	172	–	–	﹤0.01%	2934
2023 Q2	$9.95K	Buy	+172	New	+$10.4K	﹤0.01%	2912
2022 Q2	–	Sell	-108	Closed	-$9K	–	3247
2022 Q1	$9K	Hold	108	–	–	﹤0.01%	2841
2021 Q4	$10K	Hold	108	–	–	﹤0.01%	2907
2021 Q3	$14K	Hold	108	–	–	﹤0.01%	2852
2021 Q2	$12K	Hold	108	–	–	﹤0.01%	2904
2021 Q1	$16K	Hold	108	–	–	﹤0.01%	2661
2020 Q4	$12K	Hold	108	–	–	﹤0.01%	2720
2020 Q3	$8K	Hold	108	–	–	﹤0.01%	2829
2020 Q2	$12K	Hold	108	–	–	﹤0.01%	2640
2020 Q1	$12K	Hold	108	–	–	﹤0.01%	2459
2019 Q4	$17K	Hold	108	–	–	﹤0.01%	2494
2019 Q3	$16K	Buy	108 +78	+260%	+$8.69K	﹤0.01%	2520
2019 Q2	$3K	Hold	30	–	–	﹤0.01%	2998
2019 Q1	$3K	Hold	30	–	–	﹤0.01%	2922
2018 Q4	$2K	Hold	30	–	–	﹤0.01%	2961
2018 Q3	$5K	Buy	+30	New	+$5.12K	﹤0.01%	2953

Other funds holding VRCA

Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Sovran Advisors San Diego, California $1.27B AUM 18.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Ameritas Investment Partners's VRCA Position: Q2 2025 in Review

Ameritas Investment Partners sold out of Verrica Pharmaceuticals (VRCA) in Q2 2025, closing a stake of 172 shares — an estimated $762 sold.

Ameritas Investment Partners first reported a position in VRCA in Q3 2018 and held it in 23 quarters. The position peaked at $17K in Q4 2019. 58 funds tracked by Wall St. Rank hold VRCA as of Q2 2025.

Ameritas Investment Partners reported no remaining Verrica Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
Ameritas Investment Partners sold 172 Verrica Pharmaceuticals shares in Q2 2025, an estimated $762.
Ameritas Investment Partners first reported a position in Verrica Pharmaceuticals in Q3 2018 and held it in 23 quarters.
Ameritas Investment Partners's Verrica Pharmaceuticals position peaked at $17K in Q4 2019.
58 funds tracked by Wall St. Rank held Verrica Pharmaceuticals as of Q2 2025.

Based on Ameritas Investment Partners's 13F filing for Q2 2025, filed 12 Aug 2025.